Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
Frailty and risk of gastrointestinal bleeding: a prospective cohort study based on UK biobank
Chenao Zhang1,2, Qiming Huang1, Xingyu Liu1
1Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Introduction:
Frailty has been associated with various diseases. However, its impact on gastrointestinal bleeding (GIB) remains largely unexplored. This study investigates the relationship between frailty and the incidence of gastrointestinal bleeding events.
Methods:
A total of 352,060 participants from the UK Biobank with no history of gastrointestinal bleeding were included. Baseline frailty status was assessed using the Fried phenotype and categorized as non-frail, pre-frail, or frail. The primary outcome was gastrointestinal bleeding, identified through hospitalization records and death registries. Cox proportional hazard models were used to evaluate the association between frailty and gastrointestinal bleeding incidence.
Results:
Among the 352,060 participants (mean age 56.1 years), 3.6% (N = 12,747) were classified as frail, and 43.6% (N = 153,424) as pre-frail at baseline. Over a median follow-up of 14.7 years, 20,105 gastrointestinal bleeding events were recorded. Compared to non-frail individuals, frail (HR = 1.53, 95% CI: 1.44-1.62) and pre-frail (HR = 1.15, 95% CI: 1.11-1.18) individuals exhibited a significantly higher risk of gastrointestinal bleeding after multivariate adjustment (P for trend < 0.001). Subgroup and sensitivity analyses remained consistent findings.
Conclusion:
Frailty significantly elevates the risk of gastrointestinal bleeding. Early identification and targeted multidimensional interventions addressing frailty may reduce gastrointestinal bleeding events and improve patient prognosis.
Related Concept Videos
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

